表紙
市場調査レポート

米国の感染症検査市場:病院、民間検査所、ポイントオブケア(POC)検査所

2016-2020 Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

発行 Venture Planning Group 商品コード 305191
出版日 ページ情報 英文 1060 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
米国の感染症検査市場:病院、民間検査所、ポイントオブケア(POC)検査所 2016-2020 Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations
出版日: ページ情報: 英文 1060 Pages
概要

当レポートでは、米国の感染症検査市場について調査分析し、今後5年間の新興のビジネス機会、主要動向、現在/新興の診断技術、革新的な診断技術に対する潜在的な用途、検査件数・売上高の将来予測、主要企業の戦略的プロファイルなどについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 主な製品開発の機会

  • 装置
  • 試薬キットと検査システム/パネル
  • IT
  • 補助製品

第3章 分散型検査製品の設計基準

第4章 代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者のタイプ
    • 市場区分要因

第5章 潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

第6章 世界市場と技術の概要

  • 主な感染症検査
    • エイズ
    • アデノウィルス
    • エロモナス
    • 炭疽病
    • アルボウイルス
    • バベシア症
    • 細菌性血管腫症・バルトネラ類感染症
    • ブラストシスチスホミニス
    • ブルセラ症
    • カンピロバクター
    • カンジダ症
    • シャーガス病
    • 軟性下疳
    • クラミジア
    • クロストリジウムディフィシレ感染症
    • コロナウイルス
    • コクサッキーウイルス、など
  • 検査装置のレビュー:主な自動/半自動分析装置の操作性・機能・販売価格
  • 新興の診断技術
    • 分子診断
    • モノクローナル抗体
    • イムノアッセイ(免疫測定法)
    • 差分光拡散
    • IT
    • 人工知能
    • リポソーム
    • フローサイトメトリー
    • クロマトグラフィー
    • 画像診断
    • MRI
    • ゲルマイクロドロップ法
    • その他

第7章 米国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 分散化検査の論理的根拠
  • 市場規模・成長率、件数(方法別)、主要サプライヤーの売上高と市場シェア(検査別)

第8章 競合戦略

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac/PE
  • 和光純薬工業

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID17431

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers by individual test.

- Volume and sales forecasts for over 100 infectious disease assays by individual test and market segment:

Centralized Testing Hospitals Commercial/Private Laboratories Blood Banks Public Health Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

- Review of the market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,immunoassay, and other technologies and their potential applications for infectious disease testing.

- Global listings of companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - Affymetrix    - Beckman Coulter/Danaher    - Becton Dickinson    - Biomerieux    - Bio-Rad    - Cepheid    - Diamedix/Erba    - Diasorin    - Eiken Chemical    - Elitech Group    - Enzo Biochem    - Fujirebio    - Grifols    - Hologic/Gen-Probe    - ID Biomedical/GSK    - Kreatech/Leica    - Lonza    - Ortho-Clinical Diagnostics    - Qiagen    - Roche    - Scienion    - Sequenom    - SeraCare    - Siemens    - Takara Bio    - ThermoFisher    - Wallac/PE    - Wako

Contains 1,060 pages and 192 tables

Table of Contents

I. Introduction

II. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Information Technology
  • D. Auxiliary Products

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VI. Worldwide Overview of Major Tests, Technologies, and Instrumentation

  • A. Major Infectious Disease Tests
    • 1. AIDS
    • 2. Adenovirus
    • 3. Aeromonas
    • 4. Anthrax/Bacillus Anthracis
    • 5. Arboviruses
    • 6. Babesiosis
    • 7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
    • 8. Blastocystis Hominis
    • 9. Brucella
    • 10. Campylobacter
    • 11. Candida
    • 12. Chagas Disease
    • 13. Chancroid
    • 14. Chlamydia
    • 15. Clostridium Difficile
    • 16. Coronaviruses
    • 17. Coxsackieviruses
    • 18. Creutzfeldt-Jakob's Disease
    • 19. Cryptosporidium Parvum
    • 20. Cyclospora Cayetanensis
    • 21. Cytomegalovirus
    • 22. Ebola Virus
    • 23. E. Coli
    • 24. EchoVirus
    • 25. Encephalitis
    • 26. Enteroviruses
    • 27. Epstein-Barr Virus
    • 28. Giardia Lamblia
    • 29. Gonorrhea
    • 30. Granuloma Inguinale
    • 31. Hantavirus
    • 32. Helicobacter Pylori
    • 33. Hepatitis
    • 34. Herpes Simplex Virus
    • 35. Human Herpes Virus-6 (HHV-6)
    • 36. Influenza Viruses
    • 37. Legionella
    • 38. Lyme Disease
    • 39. Lymphogranuloma Venereum (LGV)
    • 40. Malaria
    • 41. Measles (Rubeola)
    • 42. Meningitis
    • 43. Microsporidium
    • 44. Mononucleosis
    • 45. Mumps
    • 46. Mycoplasma
    • 47. Papillomaviruses
    • 48. Parvovirus B19
    • 49. Pneumonia
    • 50. Polyomaviruses
    • 51. Pseudomonas Aeruginosa
    • 52. Rabies
    • 53. Respiratory Syncytial Virus (RSV)
    • 54. RhinoViruses
    • 55. RotaVirus (REOVIRUS)
    • 56. Rubella(MEASLES)
    • 57. Salmonellosis
    • 58. Septicemia
    • 59. Shigellosis
    • 60. Staphylococcus Aureus
    • 61. Streptococci
    • 62. Syphilis
    • 63. Toxoplasmosis
    • 64. Trichomonas Vaginalis
    • 65. Tuberculosis
    • 66. Vibrio
    • 67. West Nile Virus
    • 68. Yersina
  • B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Automated and Semiautomated Analyzers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VII. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Rationale for Testing Decentralization
    • 1. Overview
    • 2. Regulatory Trends
    • 3. Economic Trends
    • 4. Demographic Trends
    • 5. Technological Trends
    • 6. Social Trends
    • 7. Quality of Care
    • 8. Defensive Medicine
    • 9. Quality Control Issues
  • E. Market Size, Growth, Volume by Method, and Major Suppliers' Sales and Market Shares by Test

XI. Competitive Strategies

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Grifols/Novartis
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • U.S.A. Summary Table
  • All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Laboratories Performing Infectious Disease Tests by Market Segment
  • U.S.A.
  • Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • U.S.A.
  • Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
  • U.S.A.
  • Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
  • U.S.A.
  • All Market Segments Infectious Disease Test Volume Forecast
  • U.S.A.
  • All Market Segments Infectious Disease Test Volume by Method
  • U.S.A.
  • Hospital Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • Blood Banks Infectious Disease Test Volume Forecast
  • U.S.A.
  • Physician Office Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • Commercial/Private Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • Public Health Laboratories Infectious Disease Test Volume Forecast
  • U.S.A.
  • All Market Segments Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Blood Banks Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • Public Health Laboratories Infectious Disease Diagnostics Market Forecast
  • U.S.A.
  • HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • BEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • CMV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • EBV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Measles Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
  • U.S.A.
  • AIDS Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Candida Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chancroid Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • CMV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Echovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Enterovirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • EBV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Giardia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Influenza Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Legionella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Measles Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Meningitis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mumps Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rabies Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • RSV Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Rubella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Salmonella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Septicemia Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Shigella Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Streptococci Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Back to Top